Gene-IT Announces GenomeQuest(TM) Adoption By Biogen Idec, Inc. (Massachusetts)

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Gene-IT, a leader in biological sequence search for research and IP, today announced that it is providing its flagship GenomeQuest™ service to Biogen Idec (NASDAQ: BIIB), a global biotechnology company with leading products and capabilities in oncology, neurology and immunology.

MORE ON THIS TOPIC